A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: Comparison of patient and caregiver ratings of quality of life

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 31, Issue 2, 2008, Pages 163-168

  Brown, Paul D ^a   Decker, Paul A ^a   Rummans, Teresa A ^a   Clark, Matthew M ^a   Frost, Marlene H ^a   Ballman, Karla V ^a   Arusell, Robert M ^b   Buckner, Jan C ^a  

^a MAYO CLINIC   (United States)

^b MeritCare Roger Maris Cancer Center   (United States)

Author keywords

Caregivers; Chemotherapy; High grade glioma; Proxy ratings; Quality of life; Radiotherapy

Indexed keywords

CARMUSTINE; CISPLATIN; CORTICOSTEROID; ETOPOSIDE; GEFITINIB;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CAREGIVER; COGNITION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; QUALITY OF LIFE; SCORING SYSTEM;

ADULT; AGED; CAREGIVERS; COGNITION DISORDERS; DATA COLLECTION; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PROSPECTIVE STUDIES; PROXY; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC;

EID: 42049103960     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318149f1d3     Document Type: Article

References (45)

1. Fine HA, Dear KB, Loeffler JS, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults [comment]. Cancer. 1993;71:2585-2597.
2. Gilbert M, Armstrong T, Meyers C. Issues in assessing and interpreting quality of life in patients with malignant glioma. Semin Oncol. 2000;27(3 suppl 6):20-26.
3. Walker M, Brown J, Brown K, et al. Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma. J Neurooncol. 2003;63:179-186.
4. Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial [see comment]. J Clin Oncol. 2004;22:1583-1588.
5. Frost MH, Bonomi AE, Ferrans CE, et al. Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clin Proc. 2002;77:488-494.
6. Klein M, Taphoorn MJ, Heimans JJ, et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients [summary for patients in]. J Clin Oncol. 2001;19:4037-4047.
7. Hays RD, Vickrey BG, Hermann BP, et al. Agreement between self reports and proxy reports of quality of life in epilepsy patients. Qual Life Res. 1995;4:159-168.
8. Sneeuw KC, Aaronson NK, de Haan RJ, et al. Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke. 1997;28:1541-1549.
9. Aaronson NK. Assessing the quality of life of patients in cancer clinical trials: common problems and common sense solutions. Eur J Cancer. 1992;28A:1304-1307.
10. Blazeby JM, Williams MH, Alderson D, et al. Observer variation in assessment of quality of life in patients with oesophageal cancer. Br J Surg. 1995;82:1200-1203.
11. Slevin ML, Plant H, Lynch D, et al. Who should measure quality of life, the doctor or the patient? Br J Cancer. 1988;57:109-112.
12. Sigurdardottir V, Brandberg Y, Sullivan M. Criterion-based validation of the EORTC QLQ-C36 in advanced melanoma: the CIPS questionnaire and proxy raters. Qual Life Res. 1996;5:375-386.
13. Brown PD, Maurer MJ, Rummans TA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery. 2005;57:495-504; discussion 495-504.
14. Brown PD, Ballman KV, Rummans TA, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol. 2006;76:283-291.
15. Rao R, et al. A phase II trial of pre-irradiation chemotherapy with BCNU, cisplatin and oral etoposide combined with radiation therapy in the treatment of grade 3 astrocytoma (anaplastic astrocytoma). Neurooncology. 2002;4:374.
16. Moynihan TJ, et al. A phase II trial of pre-irradiation chemotherapy with BCNU, cisplatin and oral etoposide combined with radiation therapy in the treatment of glioblastoma (GBM). (Abstract no. 306). Program Proc Am Soc Clin Oncol. 2002;21:77.
17. Uhm JH, et al. Phase II study of ZD1839 in patients with newly diagnosed grade 4 astrocytoma (Abstract 1505). Program Proc Am Soc Clin Oncol. 2004;22:108s.
18. Osoba D. Lessons learned from measuring health-related quality of life in oncology [comment]. J Clin Oncol. 1994;12:608-616.
19. Gotay CC, et al. Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst. 1992;84:575-579.
20. McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988;18:1007-1019.
21. Osoba D, et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res. 1996;5:139-150.
22. Cella DF. Quality of life outcomes: measurement and validation. Oncology (Huntington), 1996;10(11 suppl):233-246.
23. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena [see comment]. Res Nurs Health. 1990;13:227-236.
24. Sloan JA, et al. Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc. 2002;77:367-370.
25. Decker PA, et al. Validation of single item Linear Analogue Scale Assessments (LASAs) for assessing quality of life (QOL) in patients with newly diagnosed high-grade gliomas. J Clin Oncol. 2006;24(18S pt. I):488s(Abstract 8583).
26. Weitzner MA, et al. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer. 1995;75:1151-1161.
27. Cassileth BR, et al. Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group. Qual Life Res. 1992;1:323-329.
28. Swain SM, et al. Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of life. J Clin Oncol. 1996. 14:1565-1572.
29. Braslis KG, et al. Quality of life 12 months after radical prostatectomy. Br J Urol. 1995;75:48-53.
30. McCorkle R, Quint-Benoliel J. Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease. Soc Sci Med. 1983;17:431-438.
31. Carskadon MA, et al. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 1986;9:519-524.
32. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest. 1993;103:30-36.
33. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
34. Osoba D, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139-144.
35. Sloan JA, et al. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer [see comment]. J Clin Oncol. 1998;16:3662-3673.
36. Sloan JA, Dueck A. Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. J Biopharm Stat. 2004;14:73-96.
37. Bretscher M, et al. Quality of life in hospice patients. A pilot study. Psychosomatics. 1999;40:309-313.
38. Guyatt GH, et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77:371-383.
39. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation [see comment]. Med Care. 2003;41:582-592.
40. Burns N, Grove SK. The Practice of Nursing Research: Conduct, Critique and Utilization. 2nd ed. Philadelphia: WB Saunders; 1993.
41. Tangalos EG, et al. The mini-mental state examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc. 1996;71:829-837.
42. Brown PD, et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol. 2003;21:2519-2524.
43. Sneeuw KC, et al. Value of caregiver ratings in evaluating the quality of life of patients with cancer. J Clin Oncol. 1997;15:1206-1217.
44. Sneeuw KC, et al. The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care. 1997;35:490-506.
45. Sneeuw KC, Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol. 2002;55:1130-1143.